Dr. Ojas Shah, MD

Dr. Shah practices at Columbia University Irving Medical Center in New York, New York.

Dr. Shah's NPI, 1437143278, was assigned on September 8, 2005. Dr. Shah graduated from Feinberg School of Medicine in 1996. Dr. Shah holds New York license 208100.

Dr. Shah's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Shah's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Shah is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Shah to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Shah is board certified in urology by the American Board of Urology. Dmand AI has Dr. Shah's licenses on file in 4 states: New York, Florida, New Jersey and North Carolina.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney disease, kidney removal surgery, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Shah treats.

CMS data shows 1,179 Medicare services from Dr. Shah across 13 procedure codes in 2024, for 651 Medicare patients. Medicare paid $147,809 for them.

CMS counts 651 Medicare patients who saw Dr. Shah in 2024. The largest group is 65 to 74, with 306 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 63, with 40% women.

In 2024, Dr. Shah wrote 907 Medicare Part D claims for 254 patients. 87% of them were for generic drugs. CMS names the drug for 764 of them, across 17 drugs with 11 or more claims each, at $67,986 in total drug cost. In 2023, CMS named 593 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shah for performance year 2024, reported through an alternative payment model (APM). Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shah as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 74 papers to Dr. Shah, published from 2007 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Ureteral Calculi, Kidney Calculi and Ureteroscopy. Dr. Shah has published most often in J Endourol. Dr. Shah's most frequent co-authors are Ezra Joseph Margolin, MD, Mitchell R. Humphreys, MD and Tracy Patricia Marien, MD.

Dmand AI links Dr. Shah to 2 clinical trials. Conditions studied include Kidney Calculi and Urinary Calculi.

CMS Open Payments shows 428 general payments to Dr. Shah from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Boston Scientific Corporation paid the most, $209,792. It also lists 4 research payments totaling $42,110 from 2021 to 2022.

Dmand AI lists 3 awards for Dr. Shah, most recently Best Doctors in 2023.

Dr. Shah graduated from Feinberg School of Medicine in 1996. Dr. Shah is a member of AUA.

Dr. Shah is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.